Patent Eligibility Guidance and Rejection Composition in Corporate Patenting

Technical Summary: Patent Eligibility Guidance and Rejection Composition in Corporate Patenting

Problem and Motivation
Patent office reforms often alter the specific legal objections an applicant must address without necessarily removing all barriers to a patent grant. This distinction is critical for innovation policy because firms rely on patents for licensing, financing, and competitive strategy. While obtaining a patent facilitates these outcomes, the path to grant involves satisfying multiple, overlapping legal requirements (e.g., eligibility under Section 101, novelty under Section 102, non-obviousness under Section 103, and disclosure under Section 112).

A change in one requirement, such as the United States Patent and Trademark Office's (USPTO) January 2019 Revised Patent Subject Matter Eligibility Guidance (PEG), may reduce eligibility rejections but leave other statutory grounds intact. Consequently, a decline in eligibility objections does not automatically imply a decline in overall rejection incidence or an increase in grant rates. This study investigates how the composition of first-action objections changed following the PEG and whether these changes translated into different probabilities of patent acquisition or abandonment for corporate applicants.

Methodology
The study employs a local difference-in-discontinuities design to analyze 48,695 first office actions linked to 1,197 publicly traded firms. The sample is drawn from applications filed within a 240-day window (May 2018 to September 2019) surrounding the PEG's effective date of January 7, 2019.

• Treatment and Control: The treatment group consists of 33 technology classes identified by the USPTO as "Alice-affected" (primarily software and related technologies). The control group comprises all other observed technology classes.
• Decomposition of Objections: The analysis decomposes first-action outcomes into four mutually exclusive categories:
  1. Eligibility only (Section 101).
  2. Eligibility combined with another statutory ground.
  3. Other statutory grounds only (Sections 102, 103, 112).
  4. None of the four measured statutory grounds.
• Examiner Specifications: To address potential heterogeneity in examination practices, three specifications are reported side-by-side:
  1. Hybrid groups: Uses employee numbers for matched rejection actions and examiner names for others.
  2. Examiner names: Uses normalized names across all action types.
  3. No examiner effects: Omits examiner fixed effects entirely.
• Downstream Analysis: The study tracks grant and recorded-abandonment outcomes at 24 and 36 months. It utilizes equivalence testing (Two One-Sided Tests) to determine if changes in grant probabilities fall within a ±3 percentage point margin, rather than testing for a statistically significant difference.
• Claim-Level Analysis: For 41,547 rejection actions, the study analyzes the number of claims rejected under specific statutes and the overlap of statutory grounds within single actions.

Key Results

1. Composition of Rejections:

   • Eligibility rejection rates declined in Alice-affected classes relative to the control group. Estimates for the reduction in Section 101 rejections range from −3.84 to −4.72 percentage points across the three specifications (p-values ranging from .072 to .174).
   • Crucially, this decline was concentrated in actions that combined eligibility with another ground. The "Eligibility plus another ground" category decreased by approximately 3.4 to 4.4 percentage points.
   • Concurrently, the "Other-only" (non-eligibility) rejection category increased by approximately 3.6 to 4.9 percentage points.
   • The net change in "Any-ground" rejections (the sum of all statutory rejections) was negligible, ranging from −0.60 to +0.14 percentage points and statistically indistinguishable from zero.

2. Claim-Level Evidence:

   • Among rejection actions, the number of claims rejected specifically under Section 101 declined by 1.49 to 1.59 claims per action.
   • The share of rejected claims attributed to Section 101 fell by 6.43 to 6.78 percentage points.
   • The number of claims rejected under multiple statutes also declined significantly.

3. Downstream Outcomes (Grants and Abandonment):

   • Despite the shift in objection composition, the probability of obtaining a patent grant or the rate of recorded abandonment did not show a statistically significant change relative to the control group.
   • Equivalence Tests: Grant and abandonment estimates at 24 and 36 months satisfied the ±3 percentage point equivalence criterion at the 5% level for the hybrid and examiner-name specifications. The 36-month grant estimate without examiner effects met the criterion at the 10% level.
   • This suggests that while the recorded objections changed (fewer eligibility-only or eligibility-plus-other rejections, more other-only rejections), the outcome for the applicant (grant vs. abandonment) remained stable within the observed horizon.

Significance and Claims
The paper contributes to the literature on technology transfer and patent examination by distinguishing between changes in the recorded legal grounds of examination and changes in the subsequent acquisition of patent rights.

• Mechanism of Change: The observed pattern—a decline in eligibility-plus-other rejections alongside an increase in other-only rejections, with no net change in total rejections—is consistent with the removal of eligibility objections from actions that already carried another statutory ground. This finding contradicts a hypothesis that examiners simply added new Section 112 objections to compensate for relaxed eligibility review; such an addition-only mechanism would have predicted different category movements (e.g., a rise in "eligibility-plus-other" or "other-only" without a corresponding drop in the combined category).
• Policy Implications: The study demonstrates that a reform reducing eligibility objections does not necessarily alter the overall incidence of rejections or the probability of grant for corporate applicants in the short term. The "path to grant" involves overlapping requirements; relaxing one constraint (eligibility) may simply shift the applicant's hurdle to another (novelty, non-obviousness, or disclosure) without changing the final outcome.
• Limitations: The author notes that the simultaneous issuance of Section 112 guidance on the same date limits the ability to causally attribute changes solely to the PEG. Furthermore, the study focuses on the examination phase and patent acquisition, not on the commercialization or licensing value of the resulting patents.

In summary, the findings indicate that the January 2019 guidance altered the composition of examination objections for corporate applicants in Alice-affected fields but did not significantly alter the incidence of rejections or the probability of obtaining a patent within the first three years of prosecution.